The hypothesis behind these studies is that the type of dietary fat influences atherosclerosis development through effects on LDL concentration and composition. To test this hypothesis, we will study two nonhuman primate species, the hyper-responsive cynomolgus monkey and the hypo-responsive African green monkey, fed cholesterol together with four different dietary fats [saturated, monounsaturated, polyunsaturated (n-6), and polyunsaturated (n-3)]. Measurements of plasma lipoproteins and hepatic cholesterol metabolism will be correlated with the extent and severity of coronary artery atherosclerosis. The plasma lipoprotein measurements to be made include cholesterol concentrations among classes, including LDL, HDL, and VLDL, concentrations of four apolipoproteins including apoA-I, apoA-II, apoB, and apoE, concentration of Lp(a), particle heterogeneity of LDL and HDL, and plasma cholesteryl esterification and transfer. To detect differences in the regulation of hepatic cholesterol metabolism that may be directly related to dietary modification of plasma LDL concentrations, we will measure hepatic lipoprotein and cholesterol secretion and cholesterol secretion into bile using the isolated, perfused liver. In addition, we will attempt to inhibit the cholesterol esterifying enzyme in the liver, acyl- CoA:cholesterol acyltransferase(ACAT), with specific compounds to determine the effects of this enzyme on lipoprotein particle cholesteryl ester and apoB secretion. Preliminary evidence suggests that this enzyme may be contributing cholesteryl esters to the LDL particle that increase its atherogenicity, and that some dietary fats, such as n-3 polyunsaturated fat, effectively decrease the activity of this enzyme thereby decreasing LDL atherogenicity. We will also measure the extent of cholesterol absorption in each of the animals and we will estimate the level of LDL receptor function in each of the animals with LDL turnover studies in vivo. With these measurements, we can document specific dietary effects on individual aspects of cholesterol metabolism. Each of these will then be correlated to the extent of coronary artery atherosclerosis in each of the animals. In this way, we will learn about specific aspects of lipoprotein metabolism that are correlated to atherosclerosis and are likely to play an important role in lipoprotein- mediated development of the disease. The perturbations induced by dietary fat and study of two different primate species should allow more sensitive detection of regulatory factors. Development of this information will assist in designing strategies for prevention and treatment of coronary heart disease in man, which is the overall goal of this research.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL049373-04
Application #
5214029
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Schugar, Rebecca C; Shih, Diana M; Warrier, Manya et al. (2017) The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue. Cell Rep 19:2451-2461
Pollard, Ricquita D; Fulp, Brian; Sorci-Thomas, Mary G et al. (2016) High-Density Lipoprotein Biogenesis: Defining the Domains Involved in Human Apolipoprotein A-I Lipidation. Biochemistry 55:4971-81
Rodríguez-Pérez, Celia; Ramprasath, Vanu Ramkumar; Pu, Shuaihua et al. (2016) Docosahexaenoic Acid Attenuates Cardiovascular Risk Factors via a Decline in Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Plasma Levels. Lipids 51:75-83
Warrier, Manya; Zhang, Jun; Bura, Kanwardeep et al. (2016) Sterol O-Acyltransferase 2-Driven Cholesterol Esterification Opposes Liver X Receptor-Stimulated Fecal Neutral Sterol Loss. Lipids 51:151-7
Jones, Peter J H; MacKay, Dylan S; Senanayake, Vijitha K et al. (2015) High-oleic canola oil consumption enriches LDL particle cholesteryl oleate content and reduces LDL proteoglycan binding in humans. Atherosclerosis 238:231-8
Lopez, Adam M; Chuang, Jen-Chieh; Posey, Kenneth S et al. (2015) PRD125, a potent and selective inhibitor of sterol O-acyltransferase 2 markedly reduces hepatic cholesteryl ester accumulation and improves liver function in lysosomal acid lipase-deficient mice. J Pharmacol Exp Ther 355:159-67
Liu, Mingxia; Allegood, Jeremy; Zhu, Xuewei et al. (2015) Uncleaved ApoM signal peptide is required for formation of large ApoM/sphingosine 1-phosphate (S1P)-enriched HDL particles. J Biol Chem 290:7861-70
Melchior, John T; Olson, John D; Kelley, Kathryn L et al. (2015) Targeted Knockdown of Hepatic SOAT2 With Antisense Oligonucleotides Stabilizes Atherosclerotic Plaque in ApoB100-only LDLr-/- Mice. Arterioscler Thromb Vasc Biol 35:1920-7
Ohshiro, Taichi; Ohtawa, Masaki; Nagamitsu, Tohru et al. (2015) New pyripyropene A derivatives, highly SOAT2-selective inhibitors, improve hypercholesterolemia and atherosclerosis in atherogenic mouse models. J Pharmacol Exp Ther 355:299-307
Cao, Qiang; Rong, Shunxing; Repa, Joyce J et al. (2014) Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development. Arterioscler Thromb Vasc Biol 34:1871-9

Showing the most recent 10 out of 242 publications